Go Pro
NASDAQ:BFRG

Bullfrog AI Q3 2024 Earnings Report

Bullfrog AI logo
$0.60 -0.04 (-6.78%)
As of 03:49 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Bullfrog AI EPS Results

Actual EPS
-$0.22
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Bullfrog AI Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Bullfrog AI Announcement Details

Quarter
Q3 2024
Time
After Market Closes
Conference Call Date
Friday, November 8, 2024
Conference Call Time
7:00AM ET

Upcoming Earnings

Bullfrog AI's Q3 2026 earnings is estimated for Friday, November 13, 2026, based on past reporting schedules, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

Bullfrog AI Earnings Headlines

Bullfrog AI (NASDAQ:BFRG) CEO Acquires $45,000.00 in Stock
WATCH THIS BEFORE DECEMBER 8th!!
James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has noticed it. Altucher believes the filing could matter to as many as 1,806,000 Americans in the years ahead. He explains why Musk buried it and what it could mean, free of charge.tc pixel
BullFrog AI Stock Surges Wednesday: What's Happening?
See More Bullfrog AI Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Bullfrog AI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bullfrog AI and other key companies, straight to your email.

About Bullfrog AI

Bullfrog AI (NASDAQ:BFRG) Holdings, Inc. is a biotechnology and technology company that applies artificial intelligence and machine learning to drug development and precision medicine. The company focuses on helping pharmaceutical, biotechnology and healthcare organizations analyze complex biomedical data and identify insights that may support research and clinical decision-making.

Its primary platform, bfLEAP, is designed to process and analyze large, multidimensional datasets, including clinical, genomic and other healthcare-related information. BullFrog AI provides data analytics and related services intended to assist with drug discovery, clinical development, patient stratification and the evaluation of potential therapeutic opportunities.

Based in the United States, the company operates in the life sciences and healthcare technology sectors and serves organizations seeking to incorporate advanced analytics into biomedical research. BullFrog AI became a publicly traded company in 2023. Publicly available information about its geographic reach and detailed leadership structure is limited.

View Bullfrog AI Profile